Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective Study
Pre-emptive treatment with antiemetics is required to manage early-phase NINV during niraparib maintenance therapy in patients with risk factors. Additional larger studies are needed to confi rm these fi ndings and to develop optimal preventive strategies for NINV.
Authors
- Myong Cheol Lim (ORCID: https://orcid.org/0000-0001-8964-7158)
- Se Ik Kim (ORCID: https://orcid.org/0000-0002-9790-6735)
- Hyeong In Ha (ORCID: https://orcid.org/0000-0002-7045-7976)
- Young Wook Jeong
- Ji Hyun Kim (ORCID: https://orcid.org/0000-0001-5489-1169)
- Sang-Yoon Park (ORCID: https://orcid.org/0000-0001-7982-873X)
- Dongsu Kim (ORCID: https://orcid.org/0000-0002-1960-9495)
Institutions
- Western University (CA)
- Seoul National University (KR)
- National Cancer Center (KR)
- Pusan National University Yangsan Hospital (KR)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2024-11-05
- DOI
- https://doi.org/10.4143/crt.2024.899
- Citations
- 1
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.11